As an initial step towards copy number detection in acelluar biosamples such as blood plasma, we analyzed MYCN and ALK amplification status from cfDNA in medium conditioned by neuroblastoma, medulloblastoma and colon adenocarcinoma cell lines. This evidence concerns the gene ALK and colon adenocarcinoma.